Exam 1 Flashcards

1
Q

Risk Factors of dehydration: causes of Hypovolemia

A

Excessive gastrointestinal (GI) loss: V/D, nasogastric suctioning
Excessive skin loss: diaphoresis (w/o Na & H2O replacement)
Excessive renal system losses: diuretic therapy, kidney disease, adrenal insufficiency
Third spacing: burns
Hemorrhage or plasma loss
Altered intake: anorexia, nausea, impaired swallowing, confusion, NPO (decrease intake of Na & H2O)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of Dehydration

A

⊛ Hyperventilation or excessive perspiration without water treatment
⊛ Prolonged fever
⊛ DKA
⊛ Insufficient intake (enteral feeding w/o water admin, decreased thirst sensation, aphasia)
⊛ Diabetes Insipidus
⊛ Osmotic Diuresis
⊛ Excessive intake of salt, salt tablets, or hypertonic IV fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dehydration Assessment Findings

A

⊛ Vitals: Hypothermia, tachycardia (attempt to maintain BP), thready pulse, hypotension, orthostatic hypotension, decreased central venous pressure, tachypnea, hypoxia
⊛ Neuro: dizziness syncope, confusion, vomiting, anorexia, acute weight loss
⊛ GI: thirst, dry furrowed tongue, N/V, anorexia, acute weight loss
⊛ Renal: Oliguria (decreased production and concentration of urine)
⊛ Other Findings:
- diminished cap refill, cool clammy skin, diaphoresis, sunken eyeballs, flattened neck veins, poor skin turgor and tenting
- effect is greater in older adults due to loss of elasticity of skin, decrease in glomerular filtration and concentration ability of the kidneys, loss of muscle mass, and diminished thirst reflex
- pt may have elevated temp (cause or finding)
- rapid/seizure dehydration can induce seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dehydration Interventions

A

⊛ Provide oral or IV rehydration therapy
⊛ Monitor I&O
⊛ Monitor vitals (ortho hypo, HR)
⊛ Monitor for changes in mentation and confusion (an indication of worsening fluid imbalance)
⊛ Monitor weight every 8hr while fluid replacement is in progress
assess level of gait stability. Encourage the client to use call light and ask for assistance because of the increased risk for falls
⊛ Encourage the client to change positions, rolling from side to side or standing up slowly
⊛ Collaborate with healthcare team to determine appropriate fluid volume replacement and oxygen management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dehydration Patient Teaching

A

Drink plenty of liquids to promote hydration
Causes of dehydration include: V/D, large draining wounds, or excessive stony losses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dehydration Outcome Evaluation

A

Maintains a daily fluid intake of at least 1500mL (or drinks at least 500mL more than daily output)
Maintains BP at or near their normal range
Has moist mucous membranes and normal skin turgor
Asks for assistance when ambulating
Does not fall
Can state the indications of dehydration
Starts fluid replacement at the first indication of dehydration
Correctly follows treatment plans for ongoing health problem that increase the risk of dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypokalemia Assessment Findings

A

Assessment: K+ Lab Value= <3.5
⊛ Vitals: decreased BP
Thready weak pulse, orthostatic hypotension
⊛ Neuro: altered mental status, anxiety, and lethargy that progresses to acute confusion and coma
⊛ ECG: Flattened T wave, prominent U waves, ST depression, prolonged PR interval
⊛ GI: Hypoactive bowel sounds, N/V constipation, abdominal distention, paralytic ileum can develop
⊛ Muscular: weakness, diminished deep tendon reflexes
⊛ Resp: shallow breathing
⊛ Older adults are more susceptible: decreased urine concentration leads to potassium loss, as well as taking drugs that lead to potassium loss
⊛ Disease can lead to potassium loss ask about chronic disorders and recent illnesses
⊛ Diuretics, Corticosteroids, Beta-agrenergic, Agonists or Antagonists
can increase renal potassium loss
⊛ Ask about potassium supplements or foods high in potassium (bananas, citrus juice raisins, and meat)
⊛ My have no symptoms if loss is gradual, dramatic function changes if loss is rapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypokalemia Interventions

A

⊛ Ensure adequate gas exchange, prevent pt falls, prevent injury from potassium admin, monitor response to therapy, monitor breathing effectiveness, and increase serum potassium
⊛ Drug therapy: additional potassium and drugs to prevent potassium loss
- IV potassium for severe hypokalemia
- Potassium is a sever tissue irritant, never give IM or SC
⊛ Have pt eat potassium rich foods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hyperkalemia Assessment

A

Assessment: K+ Lab Value= >5.0
Cardiac= palpitations, skipped heart beats or other cardiac irregularities, bradycardia, hypotension
ECG= tall, peaked T waves, prolonged PR intervals, flat or absent P waves, wide QRS complexes, ectopic beats may appear, complete heart block, systole, and v-fib
Neuromuscular= skeletal muscles twitches (early stages), tingling burning sensations, followed by numbness in the hands and feet and around the mouth (paresthesia), (as progresses) muscle weakness, followed by flaccid paralysis (muscle weakness moves up from hands and feet and first affects arm and leg muscles)
Respiratory= muscles are unaffected until serum K+ levels reach lethal levels
GI= increased motility with diarrhea (BM frequent and watery), and hyperactive bowl sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyperkalemia Interventions

A

Reduce serum potassium level
Prevent recurrence
Ensure patient safety
Drug Therapy: restore potassium balance through excretion and movement of potassium
Cardiac monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hyponatremia Assessment

A

Assessment: Na Lab Value=<135
Very low= seizure, coma, death
Cardio= changing in cardiac output, rapid, weak, thready pulse, peripheral pulses difficult to palpate and easily blocked, BP decreased, may have severe ortho hypo leading to severe dizziness and lightheadedness, central venous pressure low
Cardio changes with hypervolemia= bounding pulses, normal/high BP, peripheral pulses full and difficult to block (may not be palpable if edema is present)
Cerebral changes: cerebral edema and increased intracranial pressure, causes behavioral changes, alter LOC and cognition, sudden onset of acute confusion or increased confusion (often seen in older adults)
Neuromuscular= muscle weakness(worse in arms and legs), diminish deep tendon reflex
GI= increased motility causing nausea, diarrhea (BM frequent and watery), and abd cramping, hyperactive bowl sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hyponatremia Interventions

A

Drug Therapy: reduce any drugs that increase sodium loss such as diuretics
- Fluid deficit: IV saline infusion to restore sodium and fluid volume
- Fluid excess: drugs that promote the excretion of water rather than sodium
Nutrition Therapy: restores sodium balance in mild hyponatremia: fluid restrictions (may be need for long term)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hypernatremia Assessment:

A

Assessment: Na Lab Value= >145
Nervous System= altered cerebral function, (w normal or decreased fluid volumes) short attention span, agitation/ confusion, (fluid overload) lethargic, stuporous, or comatose
Skeletal muscle= mild rises/early stages= muscle twitching irregular muscle contractions; as it worsens muscles become progressively weaker; late stages= reduced/absent deep tendon reflexes
Caardio= decreased contractibility; hypovolemia= HR increased, peripheral pulses difficult to palpate and are easily blocked, pulse pressure reduces, hypotension, severe ortho hypo; hypervolemia= slow/normal bounding pulses, JVD distended (even in upright position) BP increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypernatremia Interventions

A

Drug Therapy: used tor restore fluid balance when hypernatremia caused by fluid loss
- isotonic saline (0.9% NaCl), Dextrose 5% in 0.45% NaCl
Nutrition therapy: used to ensure adequate water intake
- dietary sodium restriction may be needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypocalcemia Assessment

A

Assessment: Ca Lab Value= <9.0
Tests: Trousseau’s sign (BP cuff/1-4mins), Chvostek’s sign (tape side of face)
Cardio= HR slower/faster, weak/thready pulse, sever hypotension
ECG= prolonged ST and QR intervals
Neuromuscular= weakness, paresthesia (tingling & numbness), muscle twitching, painful cramping, severe spasms, tingling may affect lips, nose and ears (problems may signal inset of neuromuscular overstimulation and tetany)
GI= increased activity, hyperactive bowel sounds, painful abd cramping and diarrhea
skeletal= osteoporosis, bones are less dense, more brittle and fragile, may break easily w slight trauma, vertebrae become more compact and spin may bend forward, leading to overall loss of height

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hypocalcemia Interventions

A
  • Restore normal calcium levels
    Drug Therapy: direct calcium replacement (PO or IV), along with Vitamin D
    Nutrition Therapy: calcium rise foods
    Reduce environmental stimuli prevent injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hypercalcemia Assessment

A

Assessment: Ca Lab Value= >10.5
Cardio= mild: increased HR and BP, severe: dressed electrical conduction, slowed HR, measure pulse rate and BP, observe for indications of poor perfusion (cyanosis/pallor), measure/record calf circumference w soft tape measure, assess feet temp, color and cap refill
ECG= dysrhythmias, shortened QT interval
Neuromuscular= severe muscle weakness, decreased deep tendon reflex w/o paresthesia, may be confused lethargic
GI= decreased peristalsis, constipation, anorexia, N/V, abd distention and pain, hypoactive bowel sounds, assess abd size by measuring girth w soft tape measure in a life circling the abdomen at the umbilicus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hypercalcemia Interventions

A

Reduce calcium levels
Drug Therapy: stop IV solutions and oral drugs containing calcium, stop vitamin D
- Rehydration: fluid volume replacement e.g. IV NS
- Diuretics that help excrete calcium
- Drugs to prevent hypercalcemia
- Possible dialysis and cardiac monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hypomagnesemia Assessment

A

Assessment: Mg Lab Value= < 1.3
Tests= Positive Trousseau and Chvostek signs
Cardio= increased risk of hypertension, atherosclerosis, hypertrophic L ventricle, and variety of dysrhythmias (premature contractions, a-fib, v-fib, associated with greater cardiac muscle cell damage after MI
ECG= long QT intervals, shortened ST segment, prolonged PR and QRS intervals, and triggering ectopic beats
Neuromuscular= hyperactive deep tendon reflexes, numbness, tingling, and painful muscle contractions, as worsens pt may have tetany and seizuresGI= decreased intestinal smooth muscle contraction, reduced motility, anorexia nausea, constipation and abd distention, if severe paralytic ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hypomagnesium Interventions

A

Correct imbalance
Manage the specific problem that caused hypomagnesemia
Drug Therapy: drugs promoting magnesium loss discontinued, magnesium sulfate given IV w sever hypomagnesemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypermagnesium Assessment

A

Assessment: Mg Lab Value= >2.1
Cardio=bradycardia peripheral vasodilation, hypotension, cardiac arrest
ECG= prolonged PR interval w widened QRS complex
CNS= drowsy, lethargic, coma
Neuromuscular= reduced/absent deep tendon reflexes, voluntary muscle contractions become progressively weaker and then stop
Resp= has no direct affect on lungs however if lung muscles are weak, respiratory insufficiency can lead to resp failure and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypermagnesium Intervention

A

Reduce serum level
Correct underlying problem
Oral and parenteral magnesium discontinued
Magnesium-free IV fluids
Loop Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Fluid Overload Priority Care/Interventions

A

Monitor I&Os, daily weight (weight gain.loss of 1kg/day=1L), assess breath sounds, monitor for peripheral edema, maintain sodium restriction diet as prescribed, maintain fluid restriction if prescribed, encourage rest, monitor client, monitor pt receiving diuretics, position client in semi-fowler’s/ fowler’s position, and reposition to prevent tissue breakdown in edematous skin, use a pressure-reducing mattress and assess bony prominences, monitor blood sodium and potassium levels
Respiratory services can be consulted for oxygen management
Pulmonology can be consulted if fluid moves in the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Fluid Volume Excess Expected Findings

A

Vital Signs= tachycardia, bounding pulse, hypertension, tachypnea, increased central venous pressure
Neuromuscular= weakness, visual changes, altered LOC, seizures
GI= ascites, increased motility, liver enlargement
Resp= crackles, cough, dyspnea
Other signs= peripheral edema due to excess fluid in body and lungs, resulting in weight gain, distended JVD, increased urine output, skin cool to touch with pallor
Lab Test= Decreased H&H, blood osmolarity, urine sodium and urine specific gravity, BUN due to plasma dilution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Respiratory Acidosis

A

pH= <7.35
PaCO2= >45
HCO3-= 22-26

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Metabolic Acidosis

A

pH= <7.35
PaCO2= 35-45
HCO3-= <22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Respiratory Alkalosis

A

pH= >7.45
PaCO2= <35
HCO3-= 22-26

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Metabolic Alkalosis

A

pH= >7.45
PaCO2= 35-45
HCO3-= >26

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Respiratory Acidosis Assessment (Hypoventilation)

A

Increase CO2, increased/normal H+ concentration
Vitals= initial tachycardia and hypotension, as worsens, bradycardia and hypotension
Dysrhythmias= V-fib
Neuro= initial anxiety, irritability, and confusion, lethargy and possible coma
Resp= ineffective, shallow, rapid breathing
Skin= pale/cyanotic
Seen in pt with pulmonary disease, sleep apnea and obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Respiratory Acidosis Interventions

A

Drug therapy (bronchodilators and mucolytics), oxygen therapy, maintain patent airway and enhance gas exchange (positioning and breathing techniques), ventilatory support, prevent complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Metabolic Acidosis Assessment

A

Decreased HCO3- and increased H+ concentration
Vitals: bradycardia, weak peripheral pulses, hypotension, tachypnea
Neuro= headache, drowsiness, confusion
Respiratory= Rapid, deep respirations (Kussmaul respirations)
Skin= warm, dry, pink

32
Q

Metabolic Acidosis Interventions

A

Varies with causes
DKA= administer insulin
GI losses= administer antidiarrheal and provide rehydration, if blood bicarb is low, admin sodium bicarb 1mEq/kg

33
Q

Respiratory Alkalosis Assessment (Hyperventilation)

A

Decreased CO2, decreased/normal H+ concentration
Vitals: tachypnea
Neuro: inability to concentrate, numbness tingling, tinnitus, and possible loss of consciousness
Cardio= tachycardia, ventricular and atrial dysrhythmias
Resp= rapid and deep

34
Q

Respiratory Alkalosis Intervention

A

Oxygen Therapy, anxiety reduction interventions and rebreathing techniques

35
Q

Metabolic Alkalosis Assessment

A

increased HCO3-, decreased H+
Vitals: tachycardia, normotensive or hypotensive
Dysrhythmias: atrial tachycardia, ventricular issues when pH increases
Neuro: numbness, tingling, tetany, muscle weakness, hyperreflexia, confusion, convulsion
resp: Depressed skeletal muscles, resulting in ineffective breathing

36
Q

Metabolic Alkalosis Interventions

A

Varies with cause, GI losses= admin antiemetics, fluids, and electrolyte replacements, if related to K+ depletion, discount ue causative agent

37
Q

Peripheral IV Site Considerations

A

Within peripheral vessels, 26-guage (smallest) to 14-gauge (largest), Rotate sites based on clinical indications
Avoid areas of joint flexion
Choose most distal site possible
Avoid dominant side if possible
Do NOT use side of mastectomy, AV Fistula, lymph node dissection or paralysis
Limit unsuccessful attempts to 2 per clinician
Use sterile technique and monitor for Cather-related blood stream infections

38
Q

Central IV site Considerations

A

Vascular access device (VAD) placed in central circulation, specifically within superior vena cava (SVC) near junction with right atrium
Chest x-ray is done to confirm placement
Newer technologies (magnet tip locator, electrocardiogram) can also be used to detect placement
Must be placed by specifically certified person
Use sterile technique and monitor for Central line-related blood stream infections

39
Q

Local complications for peripheral IV site

A

Phlebitis
Infiltration/Extravasation
Thrombosis
Site Infection

40
Q

Site Infection

A

Infection at insertion point, port pocket or subcutaneous tunnel
Clinical Manifestations: Site is red, swollen, warm
Potential purulent or odoris exudate
Interventions/Prevention: Clean exit site, remove catheter, send for culture, cover with dry sterile dressing; Aseptic technique, Hand hygiene

41
Q

Thrombosis

A

Blood clot within vein
Clinical Manifestations: Swollen extremity, Tenderness/redness, Slowed/stopped infusion
Interventions/Prevention: Stop infusion, apply cold compress
Elevate extremity, Potential need for surgical intervention; Use EBP Venipuncture techniques

42
Q

Infiltration

A

Leakage of non-vesicant solution into tissues surrounding the vein
Clinical Manifestations: Skin is cool, tight, tender, Fluid leaking from puncture site
Interventions/Preventions: Stop Infusion, remove site, Elevate extremity, Cold/Warm Compress; Stabilize catheter
Avoid pressure on/near site – restraints/BP cuffs
Assess frequently

43
Q

Extravasation

A

Leakage of vesicant solution
Clinical Manifestations: In addition to those associated with infiltration, Blistering/tissue sloughing
Interventions/Prevention: Stop infusion, Surgical intervention may be necessary; Stabilize catheter, Avoid pressure on/near site – restraints/BP cuffs, Assess frequently

44
Q

Phlebitis

A

Inflammation of the vein
Clinical Manifestations: Pain at sight, Skin is red, inflamed, potentially hard
Interventions/Prevention: Remove site if possible, Heat and elevate extremity; Choose smallest gauge possible, Avoid areas of flexion

45
Q

Infiltration From Peripheral IV Site Treatment

A

Stop infusion and remove short peripheral catheter immediately after identification of problem
Apply sterile dressing is weeping from tissue occurs
Elevate Extremity
Warm/cold compress (warm: improve circulation and healing; cold: reducing pain and swelling)
Insert new catheter in opposite extremity
Rate the infiltration using the INS infiltration scale and document

46
Q

Central Venous Access Device Client Teaching

A

Education for prevention of CRBSI
Before insertion educate about: type of catheter, hand hygiene and aseptic technique for care of catheter and therapy, the therapy required, alternatives to the catheter and therapy, activity limitations, any s/s report immediately
Provide written information

47
Q

Priority action for a client with HF taking Digoxin, causing adverse effects

A

Monitor apical pulse rate and heart rhythm (>70bpm risk for increased mortality), report any changes in rhythm
Monitor serum digoxin and potassium levels (hypokalemia potentiates dig tox)
Older adults are more likely to develop dig tox due to decreased renal excretion
Any drug increasing workload of failing heart, also increase O2 requirement, be alert for angina in response to dig
Toxic digoxin levels or presence of hypokalemia= Increased cardiac automaticity, resulting in ectopic beats (e.g. premature ventricular contractions (PVCs))
Its with changes in potassium level (especially decrease) causes pt to be more sensitive to the drugs and cause toxicity
S/S of digoxin toxicity: vague and nonspecific; anorexia, fatigue, blurred vision, and changes in mental status (especially in older adults), nearly any dysrhythmia (PVCs most commonly noted)
Early S/S of toxicity: bradycardia, heart block, and loss of the P wave on the ECG

48
Q

Digoxin Adverse Effects

A

CNS: confusion, depression, drowsiness, extreme weakness, headache syncope
CV: Arrhythmias, heart block
EENT: Blurred vision, colored halos around objects
GI: Abd discomfort/pain, anorexia, D/N/V
Electrolyte Imbalances
Use caution when pregnant and breast feeding

49
Q

Furosemide (Lasix) Adverse Effects

A

CNS: dizziness, fever, headache, lethargy, paresthesia, restlessness, vertigo, weakness
CV: arrhythmia, elevated cholesterol and triglyceride levels, orthostatic hypotension, shock, tachycardia, thromboembolism, thrombophlebitis vertigo
EENT: Blurred, vision, deafness, dry mouth, oral irritation, ototoxicity, stomatitis, tinnitus, hearing loss, (rapid IV injection), yellow vision
ENDO: Hyperglycemia
GI: azotemia, bladder spasms, glycosuria, oliguria
HEME: Agranulocytosis (rare), eosinophilia, hemolytic anemia, leukopenia, thrombocytopenia
MS: muscle pain/spasms
SKIN: acute generalized exanthematous pustulosis, bullous pemphigoid, erythema multiform, exfoliative dermatitis, photosensitivity, pruritus purport, rash, Steve-johnson syndrome, toxic epidural necrolysis, urticaria
Other: Allergic reaction/anaphylaxis, dehydration, drug reaction with eosinophilia and systemic symptoms (DRESS),
hyperuricemia, hypocalcemia, hypochloremia, hypokalemia, hypomagnesemia, hyponatremia, hypovolemia, thirst
Use caution when pregnant and breastfeeding

50
Q

S/S Left-Sided HF

A

Decreased Cardiac Output:
- fatigue, weakness, oliguria during the day (nocturia at night), angina, confusion/ restlessness, dizziness, tachycardia/palpitations, pallor, weak peripheral pulses, cool extremities
Pulmonary Congestion:
- hacking cough, worse at night; dyspnea/breathlessness; crackles or wheezes in lungs, frothy, pink-tinged sputum, tachypnea, S3/S4 summation gallop

51
Q

S/S Right-Sided HF

A

Systemic congestion, JVD, enlarged liver and spleen, anorexia and nausea, dependent edema, distended abdomen, swollen hands and fingers, polyuria at night, weight gain, increased BP (from excessive volume), decreased BP (from failure)

52
Q

MAWDS Pt Education for HF

A

M: Medications:
- take med as prescribed and do not run out
- know purpose and side effects of each drug
- avoid NSAIDs to prevent sodium and fluid retention
A: Activity:
- stay as active as possible, don’t overdo it
- know your limits, be able to carry on a conversation while exercising
W: Weight:
- weigh each day same time same scale to monitor fluid retention
D: Diet:
- limit daily sodium intake to 2-3g as prescribed
- limit daily fluid intake to 2L
S: Symptoms:
- note any new/worsening symptoms and notify HCP immediately

53
Q

HF Priority Interventions

A

Increase gas exchange and perfusion
Reduce preload (diuretics, thiazides)
Enhance contractibility (digoxin, beta-blockers, aldosterone antagonists, HCN channel blocker)
Weigh patient daily
Monitor for worsening condition

54
Q

Right-sided HF Interventions and Patient Education

A

Monitor daily weight and I&O
Asses for SOB, and dyspnea on exertion
Administer oxygen as prescribed
Monitor vital signs and hemodynamic pressures
Position pt to maximize ventilation (high-fowlers)
Monitor diagnostic results to track progress
Assess manifestations of med toxicity (dig tox)
Encourage bed rest until stable
Encourage energy conversation by assisting with care and ADLs
Maintain dietary prescriptions as prescribed (restrict fluid and sodium intake)
Provide emotional support to client and family
If self administering dig: count pulse rate for 1 min before taking, if pulse is irregular or pulse rate outside of limitations set by provider (<60bpm or >100bpm), hold dose and contact provider; take does at same time each day, do not take at same time as antacids (atleast 2hr apart), report manifestations of toxicity (fatigue muscle weakness, confusion and loss of appetite); have blood digoxin and potassium levels checked regularly

55
Q

HF Priority Nursing Assessment

A

Assess ABCs and vitals
Assess for depression and anxiety
Assess labs values:
- electrolyte imbalance
- effects of drug therapy
- renal function: BUN, Cr
- H&H
- B-type natriuretic peptide (BNP)
- proteinuria/urine specific gravity
- ABGs
Chest X-Ray, ECG, Thallium imaging/technetium pyrophosphate scanning, Multigated acquisition (MUGA)/multigated blood pool scans
Invasive hemodynamic monitoring

56
Q

Atenolol Adverse Effects

A

CNS: depression, disorientation, dizziness, drowsiness, emotional lability, fatigue, fever, lethargy, light-headedness, short-term memory loss, vertigo
CV: arrhythmias, including bradycardia and heart block; cariogenic shock; cold arms and legs; mitral insufficiency, myocardial reinfarction; ortho hypo; Raynaud’s phenomenon
EENT: dry eyes, laryngospasm, pharyngitis
GI: diarrhea, nausea, ischemic colitis, mesenteric arty thrombosis
GU: renal failure
HEME: agranulocytosis
MS: leg pain
Resp: bronchospasm, dyspnea, pulmonary emboli, resp distress, wheezing
Skin: erythematous rash
other: allergic reaction
Use caution when progeny and breastfeeding

57
Q

Categories of BP

A

Normal= <120/<80
Prehypertensive= 120-129/<80 (or 120-139/80-89)
Stage 1 HTN= 130/139/80-89 (or 140-159/90-99)
Stage 2 HTN= ≥140/≥90 (or >160/>100)

58
Q

Warfarin Adverse Effects

A

CNS: coma, intracranial hemorrhage, loss of consciousness, syncope weakness
CV: angina, calcium uremic arteriolopathy, chest pain, hypotension
EENT: epistaxis, intraocular hemorrhage
GI: abd camps/pain, D/N/V, hepatitis, jaundice
GU: Hematuria, vaginal bleeding (abnormal)
HEME: anemia, potentially fatal hemorrhage
SKING: alopecia, ecchymosis, petechiae, pruritus, purple-toe syndorme, tissue necrosis
Other: anaphylaxis

59
Q

Warfarin Contraindications/Interactions

A
  • Bleeding/bleeding tendencies, cerebral or dissecting aneurysm, cerebrovascular hemorrhage, diverticulitis, eclampsia/preeclampsia, uncontrolled hypertension, malnutrition, pericardial effusion, pericarditis, history of warfarin induced necrosis, ophthalmic surgery, severe hepatic or renal disease
  • NSAIDS, loop diuretics, acetaminophen, erythromycin, salicylates, corticosteroids, sulfonamides, vitamin E, influenza virus vaccine, penicillins, estrogens, ahminoglycosides, beta-blockers, glucagon, thiazide diuretics, vitamin C, atorvastatin/pravastatin, herbal remedies (gingko biloba, garlic), vitamin K rich foods, nicotine patch, alcohol use, smoking
60
Q

PVD Interventions

A

Prevent/treat VTE: Encourage ambulation after anticoagulation therapy initiated, Warm moist compress, Do NOT massage affected limb
Venous Insufficiency interventions: Avoid crossing legs, Elevate legs for 20min, 4-5/day, Elevate legs above heart when in bed
Treat Varicose Veins: 3 E’s: Elastic compression hose, exercise and elevation
Medications:
- Anticoagulants (Heparin (Monitor PTT), Lovenox, Coumadin (Monitor INR), Eliquis, Xarelto)
- Antiplatelets (ASA, Plavix)
- Thrombolytic (Heparin, Lovenox)

61
Q

PAD Assessment Findings

A
  • Six P’s: Pain, Pallor (pale appearance), Pulselessness, Paresthesia (numbness), Paralysis (loss of movement), Poikilothermia (coolness)
  • Intermittent Claudication: Burning, cramping pain in legs during exercise
  • Numbness/burning sensation in feet when in bed: Pain relief when in dependent position
  • Decreased capillary refill
  • Decreased/Non-palpable pulses
  • Loss of hair on lower calf, ankle, foot
  • Dry, scaly, mottled skin
  • Thick toenails
  • Cold and cyanotic extremity
  • Pallor of extremity with elevation
  • Rubor (redness) of extremity
  • Ulcers: End of Toes or Between Toes, Pale with little granulation
62
Q

Nitroglycerin Tablet Administration

A
  • instruct pt to lie down when taking (hypotensive response can be dramatic)
  • take every 5 mins for pain relief up to 3 times
  • allow tablet to dissolve bc it is absorbed sublingually
  • check expiration date (replace 3-5 months)
  • if no relief after one dose, call 911 or call rapid response team
63
Q

Action of ASA for Angina and MI

A

Reduces inflammation, pain, and decreases platelet aggregation

64
Q

ECG Patient Education

A

Remain still and breathe normally

65
Q

MI Lab Monitoring

A

Troponin T and I rise quickly, indication of MI and cardiac necrosis

66
Q

Chest Pain Priority Interventions

A
  • Assess ABCs, defibrillate as needed
  • Provide continuous ECG monitoring
  • Obtain pt vitals
  • Assess/provide vascular access
  • Consult chest pain protocol or notify HCP or rapid response team for specific interventions
  • Obtain 12-lead ECG within 10 mins of report of chest pain
  • Provide pain relief medication and aspirin non-EC as prescribed (MONA)
  • Administer supplemental oxygen therapy to maintain an oxygen saturation greater than 90%
  • Remain calm, stay with pt if possible
  • Assess the pt’s vitals and intensity of pain 5 mins after admin of meds
  • Remedicate with prescribed drugs (if vitals remain stable), and check pt every 5 mins
  • Notify HCP if vital deteriorate
67
Q

CAD Modifiable Risk Factors

A
  • Smoking/Tobacco Use: quit smoking
  • Diet: avoid trans fatty acids, limit cholesterol and sodium intake
  • Cholesterol: check lipid levels regularly, follow health care provider’s advice for elevated cholesterol and LDL-C levels
  • Physical Activity: do moderate exercise 3x to 4x a week or walk daily for 30 minutes a day at a comfortable pace
  • Diabetes Mellitus: manage diabetes with a health care provider
  • Hypertension: Have BP checked regularly, seek health care provider’s advice is BP is elevated
  • Obesity: Avoid restrictive and fad diets, Restrict intake of saturated fats, sweetened beverages, and cholesterol-rich foods, Increase physical activity
68
Q

Complementary and Integrative Health considerations for CAD and MI

A
  • Muscle relaxation, guided imagery, music therapy, pet therapy and therapeutic touch= may reduce anxiety and depression and increase adherence to activity and exercise regimens after heart surgery
  • Adding Omega-3-fatty acids from fish and plant sources can reduce lipid levels, stabilize atherosclerotic plaques and reducing sudden death from MI (fish 2x/week or fish supplement/day)
  • Resume sexual intercourse on the advice of HCP, usually after exercise tolerance test (in general-if you can walk 1 block or 2 flights of stairs without symptoms, can usually safely resume sexual activity), suggest pt initially after intercourse after a period of rest
  • Assess pt with diabetes mellitus for ability to control hyperglycemia
  • Those who experience MI may need dual anti platelet therapy
69
Q

Insulin Glargine (Lantus) Patient Education

A

Advise patient to never share insulin pens due to risk for transmission of bloodborne pathogens
Side effects may include injection site reactions, lipodystrophy, pruritus, rash, edema, or weight gain
Advise patient to monitor for signs of hypoglycemia or hyperglycemia and to report difficulties in glycemic control
Counsel patient to administer at the same time each day
Instruct patient to carefully check the insulin label before each use to avoid medication errors
Advise patient to never mix or dilute with any other insulin or solution
Teach patient proper technique and placement of injections

70
Q

Preventing Complications from Diabetes Mellitus

A
  • Preventing injury from hyperglycemia, control BG and monitor for s/s of hyper/hypoglycemia
  • Control risk factors such as obesity, HTN, tobacco use, BP Control, smoking cessation, lipid-lowering medications and ASA
  • Yearly Eye Exam, report vision changes
  • Preventing injury from peripheral neuropathy: Annual podiatrist apt, daily foot inspection/care, report numbness/tingling, always wear proper shoes
  • Reducing the risk for kidney disease: Monitor Kidney Function, I&O’s, Report output less than 30mL/hr, monitor BP, Diuretics
    Preventing complications, Consume 2-3L of fluid/day, avoid soda, alcohol, acetaminophen, NSAID’s, report decreased output
  • Hand hygiene, and wear gloves with pt. care; Maintain strict asepsis for dressing changes, wound care,IV therapy, and catheter handling; ensure that any articles used are properly disinfected or sterilized before use, maintain good personal hygiene, wash hands frequently, never share insulin pen, get flu vaccine, wear covered footwear, wear clean socks everyday
71
Q

Foot Care Patient Education

A
  • inspect feet daily, especially ares between toes
  • wash feet daily with lukewarm water and soap, dry thoroughly
  • apply moisturizer on feet, except between toes, after bathing
  • change into clean cotton socks every day
  • do not wear the same pair of shoes 2 days in a row and only wear shoes made of breathable materials
  • check shoes for foreign objects, before putting them on. Check inside show for crack or tears in the lining
  • Buy shoes with plenty of room for toes. Buy shoes later in the day when feet are usually larger. Break in new shoes gradually
  • wear socks to keep feet warm
  • trim toenails straight across with a nail clipper and smooth them with an emery board
  • see diabetes HCP immediately if you have blisters, sores or infection. Protect area with dry, sterile dressing. Do not use tape to secure dressing to skin
  • do not treat blisters, sores, or infections with home remedies
  • do not smoke or use nicotine products
  • do not step into bath tub without checking the temperature with your wrist or thermometer
  • do not use very hot or cold water. Never use hot-water bottles, heating pads, or portable heaters to warn your feet
  • do not treat corns, blisters, bunions, calluses, or ingrown toenails yourself
  • do not go barefoot
  • do not wear sandals with open toes or straps between toes
  • do not cross your legs or wear garters or tight stocking that contract blood flow
  • do not soak your feet
72
Q

Hypoglycemia Treatment

A

Unconscious:
- Place in lateral position – prevents aspiration
- Administer: Glucagon SQ/IM, D50 or IV Dextrose
Conscious:
- Provide readily absorbable carb: 4-6oz fruit juice or regular soft drink, Glucose tablets/gel, Hard candies
- Recheck BG 15 Min After Intervention

73
Q

Lispro Insulin Administration

A
  • Give within 10 minutes of mealtime
  • Verify correct med and strength
  • Do not share insulin pens or cartridges among patients
  • 4-, 5-, or 6-mm needles recommended in all patients regardless of BMI or age; inject at a 90-degree angle except when injecting into limbs, a slim abdomen, or in thinner children; for these situations, use a lifted skin fold (4- and 5-mm needles) or a 45-degree angle (6-mm needle))
  • Use caution in patients with visual impairment who may rely on audible clicks to dial their insulin dose
  • Monitor for signs of hypoglycemia
  • if BG is low, wait to administer until sometime after meal
74
Q

S/S of Hypoglycemia

A

cool, clammy, “sweaty”, anxious, nervous, irritable, mental confusion, seizures, coma, weakness, double vision, hunger, tachycardia, and palpitations

75
Q

S/S of Hyperglycemia

A

Warm, dry, vasodilator, dehydrated, rapid deep kussmaul type, acetone odor (rotten fruit) to breath
Mental status varies from alert to stuporous to obtunded or frank coma
Acidosis: hypercapnia, abd cramping, N/V
Dehydration: decreased neck vein filling, orthostatic hypo, tachycardia, poor skin turgor

76
Q

Diet Teaching for Pt with DM

A
  • Patient should work with Registered Dietitian/Nutritionist
  • Be Consistent
  • Carbohydrates: Limit Simple Sugars, Stick to Complex Carbs
  • Low Fat/Sodium
  • Many people with DM follow carb counting diets